In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Controversies in myocardial revascularisation in stable coronary artery disease

ESC webinar

Add to calendar14/11/20120:00 14/11/20120:00 Europe/Paris Controversies in myocardial revascularisation in stable coronary artery disease European Society of Cardiology contact@escardio.org DD/MM/YYYY
Chronic Ischaemic Heart Disease (IHD)
Cardiovascular Surgery


 

 

Maarten L. Simoons and Stephan Windecker
- PROS revascularization remains the gold standard 
- CONS: drugs first!

Watch the webinar recording



  • Understand the reasons for treatment of CAD: symptom reduction and prevention of untoward events (death, MI)
  • Understand the importance of ischemia in patients with stable coronary artery disease 
  • Learn about the benefits and limitations of optimal medical treatment in patients with stable coronary artery disease.
  • Appreciate what "optimal medical treatment" contains Understand the appropriate use of revascularization in patients with stable coronary artery disease
  • Appreciate that patients with stable CAD will require lifelong optimal medical treatment and may benfit from revascularization once, or several times during their lifespan.
  • Understand the principles to select the mode of revascularization, when appropriate

 

 

 

This programme is supported by multiple educational grants including Boehringer Ingelheim  and Sanofi in the form of unrestricted educational grants.
The ESC Webinar 2012/2013 scientific programme has not been influenced in any way by its sponsors.